Skip to main content

RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

13F holders, Q2 2024

Institutional positions in RAPT Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
103
−17 vs. Q1 2024
Shares held
31.8M
−122.2K (−0.4%) vs. Q1 2024
Total value
$97.0M
−$189.8M (−66.2%) vs. Q1 2024
New holders
23
30 more added
Sold out
40
31 more reduced

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 103 institutions
Q1 2021: 78 institutionsQ2 2021: 109 institutionsQ3 2021: 106 institutionsQ4 2021: 99 institutionsQ1 2022: 85 institutionsQ2 2022: 85 institutionsQ3 2022: 98 institutionsQ4 2022: 95 institutionsQ1 2023: 106 institutionsQ2 2023: 98 institutionsQ3 2023: 96 institutionsQ4 2023: 109 institutionsQ1 2024: 122 institutionsQ2 2024: 103 institutionsQ3 2024: 94 institutionsQ4 2024: 91 institutionsQ1 2025: 92 institutionsQ2 2025: 50 institutionsQ3 2025: 65 institutionsQ4 2025: 106 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $97.0M
Q1 2021: $468.4MQ2 2021: $846.6MQ3 2021: $817.8MQ4 2021: $1.02BQ1 2022: $616.1MQ2 2022: $542.7MQ3 2022: $721.0MQ4 2022: $634.7MQ1 2023: $610.5MQ2 2023: $636.7MQ3 2023: $577.8MQ4 2023: $869.3MQ1 2024: $287.2MQ2 2024: $97.0MQ3 2024: $59.9MQ4 2024: $199.5MQ1 2025: $160.0MQ2 2025: $135.6MQ3 2025: $428.0MQ4 2025: $1.02BQ1 2026: $0Q2 2026: $0
Institutions holding RAPT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025106$1.02B
Q3 202565$428.0M
Q2 202550$135.6M
Q1 202592$160.0M
Q4 202491$199.5M
Q3 202494$59.9M
Q2 2024103$97.0M
Q1 2024122$287.2M
Q4 2023109$869.3M
Q3 202396$577.8M
Q2 202398$636.7M
Q1 2023106$610.5M
Q4 202295$634.7M
Q3 202298$721.0M
Q2 202285$542.7M
Q1 202285$616.1M
Q4 202199$1.02B
Q3 2021106$817.8M
Q2 2021109$846.6M
Q1 202178$468.4M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding RAPT in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Quest Partners LLC5$150.00%−11,125−100.0%Reduced
Daiwa Securities Group Inc.101$00.00%00.0%Unchanged
Covestor Ltd10$00.00%00.0%Unchanged
Perceptive Advisors LLC0$00.00%−1,223,472−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−420,000−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−313,262−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−275,097−100.0%Sold out
Citadel Advisors LLC0$00.00%−241,783−100.0%Sold out
Artia Global Partners LP0$00.00%−137,308−100.0%Sold out
Wellington Management Group LLP0$00.00%−80,642−100.0%Sold out
UBS Oconnor LLC0$00.00%−73,088−100.0%Sold out
Voya Investment Management LLC0$00.00%−61,834−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−57,955−100.0%Sold out
Jump Financial, LLC0$00.00%−51,500−100.0%Sold out
Polar Asset Management Partners Inc.0$00.00%−46,500−100.0%Sold out
Swiss National Bank0$00.00%−44,000−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−40,940−100.0%Sold out
HRT Financial LP0$00.00%−40,871−100.0%Sold out
Denali Advisors LLC0$00.00%−32,600−100.0%Sold out
Franklin Resources Inc0$00.00%−25,877−100.0%Sold out
Alps Advisors Inc0$00.00%−24,259−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−20,208−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−17,907−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−16,749−100.0%Sold out
Janus Henderson Group PLC0$00.00%−16,003−100.0%Sold out
MetLife Investment Management0$00.00%−15,751−100.0%Sold out
Aigen Investment Management, LP0$00.00%−14,940−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−14,743−100.0%Sold out
American International Group, Inc.0$00.00%−14,556−100.0%Sold out
Oxford Asset Management LLP0$00.00%−13,594−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−13,192−100.0%Sold out
Quantbot Technologies LP0$00.00%−11,300−100.0%Sold out
Lighthouse Investment Partners, LLC0$00.00%−11,160−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−4,479−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−4,400−100.0%Sold out
Mma Asset Management LLC0$00.00%−2,500−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−1,581−100.0%Sold out
Great West Life Assurance Co0$00.00%−1,159−100.0%Sold out
Belvedere Trading LLC0$00.00%−886−100.0%Sold out
Comerica Bank0$00.00%−222−100.0%Sold out
GAMMA Investing LLC0$00.00%−27−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−7−100.0%Sold out
Farther Finance Advisors, LLC0$00.00%−2−100.0%Sold out
Credit Suisse AG––––Not filed
Cutler Group LP––––Not filed